ValiRx Share News (VAL)
VAL Share
VAL Share
VAL Share
VAL Share
VAL
VAL Share
VAL Level 2
VAL Live
VAL Broker
VAL Directors
VAL Financial
VAL
VAL Short
VAL
Last checked at -
Fri, 27th Apr 2012 14:20
(Alliance News) - ValiRx PLC on Thursday said that it has signed an evaluation deal with Imperial College London to look at research on novel therapeutic candidates for cancer treatment.
Read more(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:
Read more(Alliance News) - ValiRx PLC on Tuesday said a requisition notice, which it received earlier in February, has been confirmed as invalid following legal advice.
Read more(Sharecast News) - ValiRx announced the signing of a significant agreement with the University of Dundee and its Drug Discovery Unit (DDU) on Monday.
Read moreValiRx PLC - Nuneaton, England-based life sciences company focused on early-stage cancer therapeutics - Signs agreement with Dundee University's drug discovery unit to access research concerning novel therapeutic candidates. The agreement will be active for a period of five years, in which ValiRx may review research projects from the unit in areas aligned with the company's focus on cancer therapeutics.
Read more(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Friday and not separately reported by Alliance News:
Read more| Friday 29 December | |
| Apollon Formularies PLC | AGM |
| Eco Atlantic Oil & Gas Ltd | AGM |
| Genedrive PLC | AGM |
| Goldplat PLC | AGM |
| Lansdowne Oil & Gas PLC | GM re capital raise |
| Marula Mining PLC | AGM |
| Microsaic Systems PLC | GM re fundraise |
| Online Blockchain PLC | AGM |
| Secure Property Development & Investment PLC | AGM |
| SkinBioTherapeutics PLC | AGM |
| Tetragon Financial Group Ltd | AGM |
| Woodbois Ltd | AGM |
| Zambeef Products PLC | AGM |
| Monday 1 January | |
| no events scheduled | |
| Tuesday 2 January | |
| no events scheduled | |
| Wednesday 3 January | |
| Jubilee Metals Group PLC | GM re equity raise |
| Thursday 4 January | |
| Rotala PLC | GM re management buyout |
| Tintra PLC | GM re cancellation, re-registering as private company |
| ValiRx PLC | GM re operational review |
| Copyright 2023 Alliance News Ltd. All Rights Reserved. |
ValiRx PLC - life science company based near Birmingham, England, which is focused on early-stage cancer therapeutics and women's health - Says 3.2 million new shares have been subscribed for at 6 pence per share via a retail offer, raising GBP192,244. Also issues 499,998 new shares via a subscription. In total, raises GBP1.8 million via placing, subscription and retail offer of 30.0 million new shares.
Read more(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:
Read more(Sharecast News) - Cancer therapeutics-focussed life science company ValiRx announced on Tuesday that its subsidiary ValiSeek has entered into an exclusive option agreement with Ambrose Healthcare, a private UK-based pharmaceutical company.
Read more(Alliance News) - ValiRx PLC on Tuesday said that ValiSeek Ltd it has entered a deal to licence VAL401 with Ambrose Healthcare Ltd, a private UK specialist pharmaceutical company.
Read more(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Tuesday.
Read more(Alliance News) - ValiRx PLC on Friday said it has signed a deal with StingRay Bio Ltd to investigate a series of drug candidates.
Read more(Sharecast News) - Life science company ValiRx announced a new partnership with StingRay Bio on Friday, aiming to explore a promising lead series of drug candidates designed for oncology applications.
Read more(Alliance News) - ValiRx PLC on Friday said it had no unpublished information that was sensitive to its share price, as it rose significantly.
Read more
Last checked at